Hively Brad (CIK 1891124) reported 13 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-08-24). Recent activity: Sell STLN (298,853 shares), Buy TOI (27,108 shares), Sell TOI (13,333 shares), Buy TOI (41,667 shares), Buy TOI (32,407 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-24 | Starling Oncology, Inc. (STLN) | Director | Sell | 298,853 | $1.9M |
| 2026-07-29 | Oncology Institute, Inc. (TOI) | Director | Buy | 27,108 | $0 |
| 2025-12-16 | Oncology Institute, Inc. (TOI) | Director | Sell | 13,333 | $50,265 |
| 2025-11-24 | Oncology Institute, Inc. (TOI) | Director | Buy | 41,667 | $0 |
| 2025-11-24 | Oncology Institute, Inc. (TOI) | Director | Buy | 32,407 | $0 |
| 2025-08-21 | Oncology Institute, Inc. (TOI) | Director | Sell | 20,221 | $82,097 |
| 2025-06-05 | Oncology Institute, Inc. (TOI) | Director | Buy | 684,528 | $581,849 |
| 2025-06-05 | Oncology Institute, Inc. (TOI) | Director | Buy | 105,320 | $50,554 |
| 2025-06-05 | Oncology Institute, Inc. (TOI) | Director | Buy | 131,297 | $245,525 |
| 2025-06-05 | Oncology Institute, Inc. (TOI) | Director | Buy | 946,460 | $804,491 |
| 2025-06-05 | Oncology Institute, Inc. (TOI) | Director | Sell | 1.9M | $5.4M |
| 2025-06-05 | Oncology Institute, Inc. (TOI) | Director | Sell | 108,532 | $311,487 |
| 2025-04-28 | Oncology Institute, Inc. (TOI) | Director | Buy | 45,280 | $47,091 |
来源：SEC Form 4 申报文件 · 截至 2026-08-24